Outcomes from Autologous Hematopoietic Cell Transplantation versus Chemotherapy Alone for the Management of Light Chain Amyloidosis.

Outcomes from Autologous Hematopoietic Cell Transplantation versus Chemotherapy Alone for the Management of Light Chain Amyloidosis. Biol Blood Marrow Transplant. 2017 Sep; 23(9):1473-1477.

View in: PubMed

subject areas

Adult
Aged
Antineoplastic Agents
Bortezomib
Female
Hematopoietic Stem Cell Transplantation
Humans
Immunoglobulin Light-chain Amyloidosis
Induction Chemotherapy
Male
Middle Aged
Multivariate Analysis
Natriuretic Peptide, Brain
Proportional Hazards Models
Proteinuria
Retrospective Studies
Stroke Volume
Transplantation, Autologous
Treatment Outcome

authors with profiles

Beatrice Concepcion